The issue of certain infectious diseases of pregnant women in everyday practice
Part I. Bacterial and parasitic infections

1. Antsaklis, A., Daskalakis, G., Papantoniou, N., et al. Prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn, 2002, 22, 12, p. 1107–1111.

2. Bauer, ME., Bateman, BT., Bauer, ST., et al. Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg, 2013, 117, 4, p. 944–50.

3. Blatt, AJ., Lieberman, JM., Hoover, DR., Kaufman, HW. Chlamydial and gonococcal testing during pregnancy in the United States. Am J Obstet Gynecol, 2012, 207, 1, p. 51–55.

4. Cicinelli, E., Matteo, M., Tinelli, R., et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci, 2014, 21, 5, p. 640–647.

5. Cortina-Borja, M., Tan, HK., Wallon, M., et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med, 2010, 7, 10 p.

6. F O, B Z. Prevention of toxoplasmosis in pregnant women in Bratislava. In: 4 th scientific congress with international participation Zoonoses-common protection oh human and animal health. Bratislava; 2013.

7. Folger, AT. Maternal Chlamydia trachomatis infections and preterm birth: the impact of early detection and eradication during pregnancy. Matern Child Health J, 2013, p. 765.

8. Gavinet, MF., Robert, F., Firtion, G., et al. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol, 1997, 35, 5, p. 1276–1277.

9. Goulet, V., King, LA., Vaillant, V., de Valk, H. What is the incubation period for listeriosis? Bmc Infect Dis, 2013, 13, p. 11.

10. Greer, LG., Sheffield, JS., Rogers, VL., et al. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol, 2010, 115, 4, p. 711–716.

11. Jones, JL., Krueger, A., Schulkin, J., Schantz, PM. Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Public Health, 2010, 57, 1, p. 27–33.

12. Kassebaum, NJ., Bertozzi-Villa, A., Coggeshall, MS., et al. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study, 2013. Lancet, 2014.

13. Kataoka, S., Yamada, T., Chou, K., et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol, 2006, 44, 1, p. 51–55.

14. Kodym, P., Geleneky, M. Prevence, diagnostika a léčba toxoplasmózy v graviditě. Actual Gyn, 2012, 4, p. 31–38.

15. Lakos, A., Solymosi, N. Maternal Lyme borreliosis and pregnancy outcome. Int J Infect Dis, 2010, 14, 6, p. e494–8.

16. Lanjouw, E., Ossewaarde, JM., Stary, A., et al. European guideline for the management of Chlamydia trachomatis infections. Int J Std Aids 2010, 21, 11, p. 729–737.

17. Lapinsky, SE. Obstetric infections. Crit Care Clin, 2013, 29, 3, p. 509–520.

18. Liesenfeld, O., Press, C., Montoya, JG., et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol, 1997, 35, 1, p. 174–178.

19. Liu, B., Roberts, CL., Clarke, M., et al. Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: a retrospective cohort study. Sex Transm Infect, 2013, 89, 8, p. 672–678.

20. Li, Z., Chen, M., Guy, R., et al. Chlamydia screening in pregnancy in Australia: integration of national guidelines into clinical practice and policy. Aust N Z J Obstet Gynaecol, 2013, 53, 4, p. 338–346.

21. Magalhaes, R., Mena, C., Ferreira, V., et al. Traditional methods for isolation of Listeria monocytogenes. Methods Mol Biol, 2014, 1157, p. 15–30.

22. Mateus, T., Silva, J., Maia, RL., Teixeira, P. Listeriosis during pregnancy: A Public Health Concern. ISRN Obstet Gynecol 2013, 2013, p. 851712.

23. McAuley, J., Boyer, KM., Patel, D., et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis, 1994, 18, 1, p. 38–72.

24. Mishori, R., McClaskey, EL., WinklerPrins, VJ. Chlamydia trachomatis infections: screening, diagnosis, and management. Am Fam Physician, 2012, 86, 12, p. 1127–1132.

25. Moffett, A., Colucci, F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest, 2014, 124, 5, p. 1872–1879.

26. Montoya, JG., Liesenfeld, O. Toxoplasmosis. Lancet, 2004, 363, 9425, p. 1965–1976.

27. Muzzio, D., Zygmunt, M., Jensen, F. The role of pregnancy-associated hormones in the development and function of regulatory B cells. Front Endocrinol (Lausanne), 2014, 5, p. 39.

28. Mylonas, I. Borreliosis during pregnancy: a risk for the unborn child? Vector Borne Zoonotic Dis, 2011, 11, 7, p. 891–898.

29. Nogareda, F., Le Strat, Y., Villena, I., et al. Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation. Epidemiol Infect, 2013, p. 1–10.

30. Ondriska, F., Catar, G., Vozarova, G. The significance of complement fixation test in clinical diagnosis of toxoplasmosis. Bratisl Lek Listy, 2003, 104, 6, p. 189–196.

31. Padmini, E., Uthra, V. Role of Ureaplasma urealyticum in altering the endothelial metal concentration during preeclampsia. Placenta, 2012, 33, 4, p. 304–311.

32. Paquet, C., Yudin, MH. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can, 2013, 35, 1, p. 78–79.

33. Pereboom, MT., Mannien, J., Rours, GI., et al. Chlamydia trachomatis infection during pregnancy: knowledge, test practices, and attitudes of Dutch midwives. Scand J Infect Dis, 2014, 46, 2, p. 107–113.

34. Peyron, F., Wallon, M., Liou, C., Garner, P. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev, 2000, 2, p. D1684.

35. Pitsouni, E., Iavazzo, C., Athanasiou, S., Falagas, ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents, 2007, 30, 3, p. 213–221.

36. Potasman, I., Oren, A., Srugo, I. Isolation of Ureaplasma urealyticum and Mycoplasma hominis from public toilet bowls. Infect Control Hosp Epidemiol, 1999, 20, 1, p. 66–68.

37. Pour, AS., Bonyadi, MR., Babaloo, Z., et al. IgG avidity test for the diagnosis of acute Toxoplasma gondii infection in early pregnancy. Iran J Immunol, 2011, 8, 4, p. 251–255.

38. Rahman, M., Chowdhury, SB., Akhtar, N., et al. Chlamydia trachomatis IgM seropositivity during pregnancy and assessment of its risk factors. Mymensingh Med J, 2014, 23, 1, p. 62–68.

39. Raynes, GC., Roberts, CL., Bell, JC., et al. Antibiotics for ureaplasma in the vagina in pregnancy. Cochrane Database Syst Rev, 2011, 9, p. D3767.

40. Rorman, E., Zamir, CS., Rilkis, I., Ben-David, H. Congenital toxoplasmosis – prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol, 2006, 21, 4, p. 458–472.

41. Rustenhoven-Spaan, I., Melkert, P., Nelissen, E., et al. Maternal mortality in a rural Tanzanian hospital: fatal Jarisch-Herxheimer reaction in a case of relapsing fever in pregnancy. Trop Doct, 2013, 43, 4, p. 138–141.

42. Savige, JA., Gilbert, GL., Fairley, KF., McDowall, DR. Bacteriuria due to Ureaplasma urealyticum and Gardnerella vaginalis in women with preeclampsia. J Infect Dis, 1983, 148, 3, p. 605.

43. Siso, C., Gonce, A., Bosch, J., et al. Listeriosis in pregnancy: a secular trend in a tertiary referral hospital in Barcelona. Eur J Clin Microbiol Infect Dis, 2012, 31, 9, p. 2125–2132.

44. Strobino, B., Abid, S., Gewitz, M. Maternal Lyme disease and congenital heart disease: A case-control study in an endemic area. Am J Obstet Gynecol, 1999, 180, 3 Pt 1, p. 711–716.

45. Strobino, BA., Williams, CL., Abid, S., et al. Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients. Am J Obstet Gynecol, 1993, 169, 2 Pt 1, p. 367–374.

46. Vestník Ministerstva zdravotníctva Slovenskej republiky,čiastka 52. In; 2006.

47. Viscardi, RM. Ureaplasma species: role in diseases of prematurity. Clin Perinatol, 2010, 37, 2, p. 393–409.

48. Viscardi, RM. Ureaplasma species: role in neonatal morbidities and outcomes. Arch Dis Child Fetal Neonatal Ed, 2014, 99, 1, p. F87–92.

49. Viscardi, RM., Manimtim, WM., Sun, CC., et al. Lung pathology in premature infants with Ureaplasma urealyticum infection. Pediatr Dev Pathol, 2002, 5, 2, p. 141–150.

50. Vouga, M., Greub, G., Prod'Hom, G., et al. Treatment of genital mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications. Clin Microbiol Infect, 2014, 20, 10, p. 1074–1079.

51. Waites, KB., Xiao, L., Paralanov, V., et al. Molecular methods for the detection of Mycoplasma and Ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn, 2012, 14, 5, p. 437–450.

52. Yanaba, K., Bouaziz, JD., Haas, KM., et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28, 5, s. 639–650.